Insider Stock Trading History of Squinto Stephen P


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Squinto Stephen P since year 2005. The trader's CIK number is 1231954. At the time of this reporting, Squinto Stephen P is the EVP, Chief Global Ops. Officer of Alexion Pharmaceuticals Inc . (stock ticker symbol ALXN). See this page for all insider trading activities at Alexion Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Squinto Stephen P since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-10-27 ALXN Alexion Pharmaceuticals Inc Option Ex 5,550 60.77 337,273
2014-10-27 ALXN Alexion Pharmaceuticals Inc Sale 5,910 188.68 1,115,098
2014-10-03 ALXN Alexion Pharmaceuticals Inc Option Ex 10,025 42.66 427,666
2014-10-03 ALXN Alexion Pharmaceuticals Inc Sale 10,025 172.45 1,728,811
2014-09-24 ALXN Alexion Pharmaceuticals Inc Sale 76 159.50 12,122
2014-08-04 ALXN Alexion Pharmaceuticals Inc Sale 1,662 157.42 261,632
2014-02-10 ALXN Alexion Pharmaceuticals Inc Sale 1,635 167.31 273,551
2014-02-07 ALXN Alexion Pharmaceuticals Inc Sale 1,620 156.53 253,578
2014-02-06 ALXN Alexion Pharmaceuticals Inc Sale 3,800 155.11 589,418
2014-02-06 ALXN Alexion Pharmaceuticals Inc Option Ex 3,800 93.83 356,554
2014-02-04 ALXN Alexion Pharmaceuticals Inc Option Ex 28,739 59.57 1,711,896
2014-02-03 ALXN Alexion Pharmaceuticals Inc Sale 852 157.14 133,883
2014-02-04 ALXN Alexion Pharmaceuticals Inc Sale 36,137 155.24 5,610,016
2014-01-29 ALXN Alexion Pharmaceuticals Inc Sale 1,118 133.26 148,984
2013-11-04 ALXN Alexion Pharmaceuticals Inc Option Ex 14,125 32.78 463,017
2013-11-04 ALXN Alexion Pharmaceuticals Inc Sale 14,125 124.10 1,752,983
2013-10-28 ALXN Alexion Pharmaceuticals Inc Option Ex 40,037 86.36 3,457,395
2013-10-28 ALXN Alexion Pharmaceuticals Inc Sale 41,037 124.24 5,098,313
2013-09-24 ALXN Alexion Pharmaceuticals Inc Sale 304 112.54 34,212
2013-09-13 ALXN Alexion Pharmaceuticals Inc Sale 1,000 114.37 114,370
2013-08-02 ALXN Alexion Pharmaceuticals Inc Option Ex 14,125 32.78 463,017
2013-08-02 ALXN Alexion Pharmaceuticals Inc Sale 14,125 115.54 1,632,002
2013-08-02 ALXN Alexion Pharmaceuticals Inc Option Ex 14,125 32.78 463,017
2013-08-02 ALXN Alexion Pharmaceuticals Inc Sale 14,125 115.54 1,632,002
2013-07-30 ALXN Alexion Pharmaceuticals Inc Sale 1,120 110.86 124,163
2013-07-12 ALXN Alexion Pharmaceuticals Inc Sale 18,000 119.90 2,158,200
2013-07-12 ALXN Alexion Pharmaceuticals Inc Option Ex 18,000 20.44 367,920
2013-07-01 ALXN Alexion Pharmaceuticals Inc Option Ex 44,125 32.78 1,446,417
2013-07-01 ALXN Alexion Pharmaceuticals Inc Sale 44,125 95.95 4,233,793
2013-04-29 ALXN Alexion Pharmaceuticals Inc Option Ex 36,499 32.78 1,196,437
2013-04-29 ALXN Alexion Pharmaceuticals Inc Sale 36,499 99.24 3,621,978
2013-03-08 ALXN Alexion Pharmaceuticals Inc Sale 20,000 91.69 1,833,800
2013-03-08 ALXN Alexion Pharmaceuticals Inc Option Ex 20,000 20.44 408,800
2013-02-04 ALXN Alexion Pharmaceuticals Inc Sale 2,572 96.08 247,104
2013-01-28 ALXN Alexion Pharmaceuticals Inc Sale 715 94.50 67,567
2013-01-29 ALXN Alexion Pharmaceuticals Inc Sale 767 94.32 72,343
2012-07-31 ALXN Alexion Pharmaceuticals Inc Sale 1,015 105.01 106,585
2012-07-27 ALXN Alexion Pharmaceuticals Inc Sale 100,668 107.11 10,782,750
2012-07-27 ALXN Alexion Pharmaceuticals Inc Option Ex 100,000 20.44 2,044,000
2012-07-09 ALXN Alexion Pharmaceuticals Inc Option Ex 50,000 17.98 899,000
2012-07-09 ALXN Alexion Pharmaceuticals Inc Sale 50,000 101.04 5,052,150
2012-06-06 ALXN Alexion Pharmaceuticals Inc Option Ex 50,000 17.65 882,499
2012-06-06 ALXN Alexion Pharmaceuticals Inc Sale 50,000 90.00 4,500,000
2012-02-17 ALXN Alexion Pharmaceuticals Inc Option Ex 55,260 14.78 816,798
2012-02-17 ALXN Alexion Pharmaceuticals Inc Sale 55,260 81.65 4,511,868
2012-02-03 ALXN Alexion Pharmaceuticals Inc Option Ex 13,000 .00 0
2012-01-27 ALXN Alexion Pharmaceuticals Inc Sale 663 74.41 49,333
2012-01-30 ALXN Alexion Pharmaceuticals Inc Sale 3,004 74.51 223,828
2012-01-10 ALXN Alexion Pharmaceuticals Inc Sale 562 75.00 42,150
2011-10-24 ALXN Alexion Pharmaceuticals Inc Option Ex 52,740 11.92 628,660
2011-10-24 ALXN Alexion Pharmaceuticals Inc Sale 52,740 69.22 3,650,926
2011-07-26 ALXN Alexion Pharmaceuticals Inc Option Ex 28,000 10.29 288,120
2011-07-26 ALXN Alexion Pharmaceuticals Inc Sale 28,000 57.34 1,605,520
2011-07-27 ALXN Alexion Pharmaceuticals Inc Sale 669 57.27 38,313
2011-07-11 ALXN Alexion Pharmaceuticals Inc Sale 502 50.00 25,100
2011-03-02 ALXN Alexion Pharmaceuticals Inc Option Ex 5,000 20.58 102,899
2011-03-02 ALXN Alexion Pharmaceuticals Inc Sale 5,000 99.11 495,550
2011-02-18 ALXN Alexion Pharmaceuticals Inc Option Ex 10,000 20.58 205,799
2011-02-18 ALXN Alexion Pharmaceuticals Inc Sale 10,000 94.42 944,200
2011-01-27 ALXN Alexion Pharmaceuticals Inc Sale 1,330 84.70 112,651
2011-01-18 ALXN Alexion Pharmaceuticals Inc Sale 34,346 83.84 2,879,568
2011-01-18 ALXN Alexion Pharmaceuticals Inc Option Ex 34,000 13.36 454,070
2011-01-10 ALXN Alexion Pharmaceuticals Inc Sale 280 81.27 22,755
2010-11-03 ALXN Alexion Pharmaceuticals Inc Sale 10,000 70.14 701,400
2010-11-03 ALXN Alexion Pharmaceuticals Inc Option Ex 10,000 10.36 103,600
2010-11-03 ALXN Alexion Pharmaceuticals Inc Sale 10,000 70.14 701,400
2010-11-03 ALXN Alexion Pharmaceuticals Inc Option Ex 10,000 10.36 103,600
2010-11-03 ALXN Alexion Pharmaceuticals Inc Sale 10,000 70.14 701,400
2010-11-03 ALXN Alexion Pharmaceuticals Inc Option Ex 10,000 10.36 103,600
2010-09-13 ALXN Alexion Pharmaceuticals Inc Sale 12,416 60.89 756,010
2010-09-13 ALXN Alexion Pharmaceuticals Inc Option Ex 12,416 10.92 135,582
2010-07-16 ALXN Alexion Pharmaceuticals Inc Sale 332 51.08 16,958
2010-07-12 ALXN Alexion Pharmaceuticals Inc Sale 249 51.91 12,925
2010-02-16 ALXN Alexion Pharmaceuticals Inc Option Ex 16,000 13.79 220,640
2010-02-16 ALXN Alexion Pharmaceuticals Inc Sale 16,000 46.60 745,600
2010-01-19 ALXN Alexion Pharmaceuticals Inc Sale 332 47.22 15,677
2010-01-11 ALXN Alexion Pharmaceuticals Inc Sale 1,465 47.67 69,836
2009-08-24 ALXN Alexion Pharmaceuticals Inc Sale 45,800 45.00 2,061,091
2009-08-24 ALXN Alexion Pharmaceuticals Inc Option Ex 45,800 16.83 770,813
2009-08-04 ALXN Alexion Pharmaceuticals Inc Option Ex 4,200 32.25 135,450
2009-08-04 ALXN Alexion Pharmaceuticals Inc Sale 4,200 45.00 189,000
2009-07-16 ALXN Alexion Pharmaceuticals Inc Sale 317 38.96 12,350
2009-07-10 ALXN Alexion Pharmaceuticals Inc Sale 318 36.93 11,743
2009-03-16 ALXN Alexion Pharmaceuticals Inc Sale 2,717 34.25 93,057
2009-03-10 ALXN Alexion Pharmaceuticals Inc Sale 319 32.34 10,316
2009-01-16 ALXN Alexion Pharmaceuticals Inc Sale 1,348 36.81 49,619
2009-01-12 ALXN Alexion Pharmaceuticals Inc Sale 375 34.48 12,929
2008-09-11 ALXN Alexion Pharmaceuticals Inc Sale 319 40.20 12,823
2008-07-10 ALXN Alexion Pharmaceuticals Inc Sale 159 75.75 12,044
2008-05-19 ALXN Alexion Pharmaceuticals Inc Option Ex 35,827 17.87 640,156
2008-05-19 ALXN Alexion Pharmaceuticals Inc Sale 35,827 69.81 2,500,975
2008-03-10 ALXN Alexion Pharmaceuticals Inc Sale 159 56.05 8,911
2008-01-10 ALXN Alexion Pharmaceuticals Inc Sale 712 69.02 49,142
2007-11-05 ALXN Alexion Pharmaceuticals Inc Option Ex 33,465 21.00 702,765
2007-11-05 ALXN Alexion Pharmaceuticals Inc Sale 34,998 75.03 2,625,899
2007-09-10 ALXN Alexion Pharmaceuticals Inc Sale 209 65.31 13,649
2007-07-25 ALXN Alexion Pharmaceuticals Inc Sale 25,000 56.70 1,417,500
2007-07-25 ALXN Alexion Pharmaceuticals Inc Option Ex 25,000 10.00 249,874
2007-06-01 ALXN Alexion Pharmaceuticals Inc Option Ex 25,000 9.25 231,250
2007-06-01 ALXN Alexion Pharmaceuticals Inc Sale 25,000 48.50 1,212,500
2007-03-12 ALXN Alexion Pharmaceuticals Inc Sale 758 37.15 28,159
2006-02-15 ALXN Alexion Pharmaceuticals Inc Option Ex 5,000 10.50 52,500
2006-02-15 ALXN Alexion Pharmaceuticals Inc Sale 5,000 35.05 175,250

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Squinto Stephen P (EVP, Chief Global Ops. Officer of Alexion Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.